InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Pronovost Peter, Director. Officer active across 1 companies, notably Cantel Medical CORP. In total, 2 disclosures have been published. The latest transaction was filed on 2 June 2021 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€2m22,970.431 shares@ €66.004100.0% of flow
Common Stock, par value $.10 per share
SEC:0001104659-21-075863·
€2m22,970.431 shares@ €66.00450.0% of flow
Common Stock, par value $.10 per share
SEC:0001104659-21-075863:0·
2 of 2 declarations
About Pronovost Peter
Peter Pronovost is a Director at CANTEL MEDICAL CORP. In this role, he contributes to the governance of the company and strategic direction. His experience in the medical sector allows him to make significant contributions to the company's leadership.
